MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 193 filers reported holding NEKTAR THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$27,206
-69.4%
38,705
-1.7%
0.00%
-100.0%
Q4 2022$89,021
-25.2%
39,390
+5.7%
0.00%
-50.0%
Q3 2022$119,0000.0%37,283
+19.2%
0.00%0.0%
Q2 2022$119,000
-16.8%
31,286
+17.6%
0.00%0.0%
Q1 2022$143,000
-58.1%
26,594
+5.5%
0.00%
-33.3%
Q4 2021$341,000
-88.3%
25,215
-84.4%
0.00%
-89.7%
Q3 2021$2,910,000
+6.5%
162,044
+1.8%
0.03%
+7.4%
Q2 2021$2,732,000
-16.2%
159,187
-2.3%
0.03%
-20.6%
Q1 2021$3,260,000
+13.4%
162,979
-3.7%
0.03%
+3.0%
Q4 2020$2,876,000
+4.0%
169,163
+1.5%
0.03%
-10.8%
Q3 2020$2,766,000
-27.2%
166,702
+1.7%
0.04%
-31.5%
Q2 2020$3,798,000
+30.0%
163,974
+0.2%
0.05%
+10.2%
Q1 2020$2,922,000
-15.1%
163,672
+2.6%
0.05%
+11.4%
Q4 2019$3,442,000
+706.1%
159,475
+580.4%
0.04%
+633.3%
Q3 2019$427,000
-48.2%
23,440
+1.1%
0.01%
-50.0%
Q2 2019$825,000
+5.4%
23,186
-0.4%
0.01%
+9.1%
Q1 2019$783,000
+2.8%
23,290
+0.5%
0.01%
-15.4%
Q4 2018$762,000
-43.7%
23,175
+4.4%
0.01%
-31.6%
Q3 2018$1,353,000
+33.6%
22,198
+7.0%
0.02%
+26.7%
Q2 2018$1,013,000
-90.5%
20,745
-79.4%
0.02%
-90.9%
Q1 2018$10,678,000
+188.9%
100,489
+62.4%
0.16%
+194.6%
Q4 2017$3,696,00061,8940.06%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2023
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders